CX3CL1 and systemic sclerosis: We demonstrate that CX3CL1 is associated with baseline severity of ILD and progression of ILD, and identified CX3CR1 expressing plasma cells as a novel recruited interstitial lung effector cell population in SSc-ILD, suggesting it may contribute to the pathobiology of SSc-ILD.